Delivery Order SPE2DB22D9130-SPE2DB25FE0FW
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 15, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA valued at approximately $500 million...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,166.24 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. The award, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a delivery order under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with DLA valued at approximately $500 million through November 2026. The delivery order carries no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $2,083.12 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. This award, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. The...
- The Defense Logistics Agency awarded a $20,830.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 24, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be fulfilled at the contractor's facility in Park Ridge, Illinois. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $1,562.31 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, effective July 25, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,603.85 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, a contraceptive implant device. This firm fixed-price delivery order, awarded on August 21, 2025, with an ultimate completion date of September 12, 2025, represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The contract carries no set-aside designation, allowing the woman-owned small business to...
- The Defense Logistics Agency awarded a $2,603.85 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg contraceptive systems on July 29, 2025, with an ultimate completion date of August 19, 2025. This delivery order was issued without a set-aside designation and is being performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, is the prime contractor on this award. This delivery order...
- The Defense Logistics Agency awarded a $7,811.55 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. The award, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, with a ceiling value of $26,038.50. The award, announced on August 18, 2025, is classified as a firm fixed-price delivery order with an ultimate completion date of September 9, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,166.24 to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems, with an ultimate completion date of September 15, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a...
- SPE2DB22D9130Indefinite Delivery Contract
- SPE2DB22D9130-SPE2DB25FE0FWDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 29, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be performed at the vendor's Park Ridge facility and represents a single purchase under the company's broader pharmaceutical supply arrangements with DLA. This delivery order is issued under DMS Pharmaceutical Group's substantial Indefinite Delivery Contract with the Defense Logistics Agency valued at $500 million through November 2026, which authorizes firm fixed-price purchases of a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide. The Mirena contraceptive implant delivery exemplifies the vendor's established role as a critical supplier of branded and generic prescription drugs, biologics, and medical consumables to military health facilities. As a long-standing federal contractor registered in the System for Award Management since 2001, DMS Pharmaceutical Group has demonstrated consistent capability in pharmaceutical distribution to government healthcare systems across multiple product categories including specialty medications, injections, and contraceptive devices.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/8/25 |